Key Points:

• The October 7 calendar lists 10 expected pricing events, but most are ETFs, investment vehicles or transactions involving already-public companies rather than conventional operating-company IPOs.
• Bradbury Capital’s Nasdaq debut follows a completed SPAC business combination, while AfterNext Acquisition I represents a new $100 million blank-check offering.
• SCWorx is returning to Nasdaq trading through a resale registration rather than a new capital raise, reinforcing the gap between headline IPO activity and genuine primary equity issuance.

Ten Calendar Events Mask a Narrower IPO Pipeline

The U.S. IPO calendar shows 10 expected events on October 7, the busiest day listed so far for the October 4–10 period. But the headline count overstates the amount of new operating-company equity reaching investors. The lineup includes four ETF or fund-related entries, a SPAC unit offering, a completed business combination and the reinstatement of an existing Nasdaq-listed company. The result is a market that remains active across public-market structures without showing the broad reopening of conventional IPO supply that a 10-event calendar might imply.

Bradbury Capital Brings De-SPAC Activity Back Into Focus

Bradbury Capital is the most notable operating-company transaction on the calendar, but its Nasdaq debut is the result of a business combination rather than a traditional IPO. Technology & Telecommunication Acquisition Corporation completed its merger with Bradbury Capital Holdings on October 6, with the combined company changing its name to Bradbury Capital Inc. and beginning trading under BBCI, alongside warrants under BBCIW.

The transaction also included a $5 million PIPE investment for 625,000 ordinary shares. That provides some incremental capital alongside the merger, but the structure remains fundamentally different from a conventional IPO in which an operating company markets newly issued shares directly to public investors.

AfterNext Adds Genuine SPAC Supply

AfterNext Acquisition I provides a clearer example of primary public-market fundraising. The SPAC is expected to offer 10 million units at $10 each, targeting approximately $100 million in gross proceeds. Each unit contains a Class A ordinary share, a right and a warrant, giving investors exposure to a future business combination rather than an operating company at the time of listing.

That distinction matters for interpreting market demand. SPAC issuance can demonstrate investor willingness to commit capital to future transactions, but it does not provide the same valuation signal as a conventional IPO with operating results, revenue growth and a defined public-company valuation.

SCWorx Highlights the Difference Between Listing and Fundraising

SCWorx adds another technically significant event to the calendar, but it is not a new IPO. Nasdaq trading is scheduled to resume after the company regained compliance with the exchange’s continued-listing requirements. Trading had been suspended since April, and Nasdaq approved continued listing following the company’s successful reconsideration request.

The company’s existing S-1 registration covers the resale of up to 53.2 million shares by selling stockholders, and SCWorx stated that it would not receive proceeds from those resale transactions. That makes the event more relevant to liquidity and potential shareholder dilution than to fresh primary capital formation.

ETFs Account for Much of the Remaining Activity

The other entries include First Trust, Amplify, Harris Oakmark, Russell Investments, The RBB Fund and Direxion investment vehicles. These products expand the day’s securities activity, but they should not be interpreted as evidence of a broad wave of operating-company IPOs. The calendar therefore provides a useful reminder that exchange listings and new equity issuance are not interchangeable measures of IPO-market health.

What the U.S. IPO Market Is Watching Next

The more important signal from October 7 is the composition of issuance rather than the 10-event headline. Investors are seeing continued access to public markets through SPACs, de-SPAC transactions, fund launches and secondary registrations, while conventional IPO supply remains comparatively narrow. The next meaningful test will be whether upcoming operating-company offerings can attract sufficient institutional demand to price and trade successfully without substantial valuation concessions.